Pharmaceuticals
10 Eli Lilly business development leaders
These ten Eli Lilly business development leaders hold director, senior director, executive director and vice president roles in corporate business development, transactions and M&A, external innovation and strategic alliances at Eli Lilly and Company. A reader can learn how business development leaders work at Eli Lilly from people who have held the role.
Professionals to explore
01—10Chad D. Walls
LinkedInExperience: Senior Director - Corporate Business Development · Eli Lilly and Company
Senior Director - Corporate Business Development at Eli Lilly and Company since October 2022, at director level in general management. He moved into business development from Lilly's medical organization, where he was Senior Director - Field Medical Scientific Strategy and earlier a clinical research scientist in global medical affairs for immunology.
David Kutoloski
LinkedInExperience: Director - Corporate Business Development · Eli Lilly and Company
Director - Corporate Business Development at Eli Lilly and Company since May 2013; his profile says he is responsible for licensing innovation to fuel pipeline growth, with a focus that includes global late-phase opportunities. He was previously Finance Director - Biomedicines at Lilly (2010–2013).
Jeremy Huckstep
LinkedInExperience: Director Strategic Alliances · Eli Lilly and Company
Director Strategic Alliances at Eli Lilly and Company since December 2018; his profile says he manages key strategic collaborations to maximize their value while mitigating risks, and supports M&A integration at Lilly. He was earlier an Alliances Manager and a Business Development Forecaster at Lilly.
Jonathan Wu
LinkedInExperience: Senior Director, Corporate Business Development, Transactions and M&A · Eli Lilly and Company
Senior Director, Corporate Business Development, Transactions and M&A at Eli Lilly and Company since November 2025. He was previously Senior Director, Business Development at CARGO Therapeutics (2024–2025) and Senior Director, Corporate Development & Pipeline Strategy at CytomX Therapeutics (2023–2024).
Lydia Qiao
LinkedInExperience: Executive Director, Commercial Partnership · Eli Lilly and Company
Executive Director, Commercial Partnership at Eli Lilly and Company since January 2022, based in Shanghai; her profile says the role expanded from business development to managing alliances, with four alliance partners contributing about 40% of Lilly China revenue. She was earlier Director of Business Development at Lilly and BD Director at Sanofi (2013–2020).
Rohit Khandelwal
LinkedInExperience: Executive Director - Business Development & Strategy (Lilly International) · Eli Lilly and Company
Executive Director - Business Development & Strategy (Lilly International) at Eli Lilly and Company since March 2023, and Sr. Director - Business Development Strategy Operations for Lilly International since 2022. He earlier was a business development advisor for South Asia, the Middle East, Turkey and Africa, and a finance director for South ASEAN at Lilly.
Ronit Rafaeloff-Phail
LinkedInExperience: Sr. Director, External Innovation - Corporate Business Development · Eli Lilly and Company
Sr. Director, External Innovation - Corporate Business Development at Eli Lilly and Company since May 2015, after serving as Director, Global External R&D (2013–2015). Her profile describes identification, technical assessment and due diligence of in-licensing opportunities, drawing on more than 20 years of drug discovery and development experience.
Samantha Johnson
LinkedInExperience: Senior Director Corporate Business Development · Eli Lilly and Company
Senior Director Corporate Business Development at Eli Lilly and Company since September 2024, after serving as Director Global Strategic Partnerships Diabetes (2021–2024). She was earlier International Brand Leader Diabetes Marketing and Director, Ethics & Compliance UK, Ireland & Nordics at Lilly.
Timothy Dolan
LinkedInExperience: Vice President of Business Development · Eli Lilly and Company
Vice President of Business Development at Eli Lilly and Company since January 2016, after serving as Director, Business Development (2009–2015) and Manager, Business Development (2006–2009). He was earlier Manager, Office of Alliance Management (2002–2006) and a Business Development Associate (2000–2002) at Lilly; his profile cites competency in business development, alliance management and law.
Yuxi Lin
LinkedInExperience: Senior Director, Business Development Strategy & Growth · Eli Lilly and Company
Senior Director, Business Development Strategy & Growth at Eli Lilly and Company since August 2024, based in San Francisco, after serving as Senior Director, Venture Science at Lilly (2022–2024). Earlier roles include program and project management at Autobahn Labs and VP of Due Diligence at Biotech Connection - Bay Area.
Choose the right perspective
Match the person's scope to your question, since late-stage licensing, transactions and M&A, external innovation, international business development and alliance management involve different work. Check which region and deal stage the person's role covers, since that shapes what they can speak to.
Questions to take into the conversation
- 01How does a large pharmaceutical company decide which external innovation to license?
- 02How are transaction teams organized for licensing deals compared with acquisitions?
- 03How does alliance management maximize the value of a collaboration after signing?
Reaching Eli Lilly business development leaders
How can I contact one of these Eli Lilly business development leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Eli Lilly and Company, based on profile data retrieved on October 9, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Eli Lilly business development leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Eli Lilly business development leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal